Targeting the NLRP3 inflammasome in cardiovascular diseases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting the NLRP3 inflammasome in cardiovascular diseases

Published:2022-08 Issue: Volume:236 Page:108053
ISSN:0163-7258
Container-title:Pharmacology & Therapeutics
language:en
Short-container-title:Pharmacology & Therapeutics

Author:

Toldo Stefano,Mezzaroma Eleonora,Buckley Leo F.,Potere Nicola,Di Nisio Marcello,Biondi-Zoccai Giuseppe,Van Tassell Benjamin W.,Abbate Antonio

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference288 articles.

1. Comparative safety of interleukin-1 blockade with anakinra in patients with ST-segment elevation acute myocardial infarction (from the VCU-ART and VCU-ART2 pilot studies);Abbate;The American Journal of Cardiology,2015

2. Interleukin-1 blockade with anakinra to prevent adverse cardiac remodeling after acute myocardial infarction (Virginia Commonwealth University Anakinra Remodeling Trial [VCU-ART] Pilot study);Abbate;The American Journal of Cardiology,2010

3. Alterations in the interleukin-1/interleukin-1 receptor antagonist balance modulate cardiac remodeling following myocardial infarction in the mouse;Abbate;PLoS One,2011

4. Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction;Abbate;Circulation,2008

5. Interleukin-1 and the inflammasome as therapeutic targets in cardiovascular disease;Abbate;Circulation Research,2020

Cited by 129 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stem cell-derived exosomes prevent the development of thoracic aortic aneurysm/dissection by inhibiting AIM2 inflammasome and pyroptosis;Extracellular Vesicle;2024-12

2. Early inhibition of the ATM/p53 pathway reduces the susceptibility to atrial fibrillation and atrial remodeling following acute myocardial infarction;Cellular Signalling;2024-10

3. Overview of pyroptosis mechanism and in-depth analysis of cardiomyocyte pyroptosis mediated by NF-κB pathway in heart failure;Biomedicine & Pharmacotherapy;2024-10

4. At the heart of inflammation: Unravelling cardiac resident macrophage biology;Journal of Cellular and Molecular Medicine;2024-09

5. Clinical Utility of Rilonacept for the Treatment of Recurrent Pericarditis: Design, Development, and Place in Therapy;Drug Design, Development and Therapy;2024-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3